查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗体药物复合体受託製造的全球市场:考察与预测 (到2028年)
市场调查报告书
商品编码
1241279

抗体药物复合体受託製造的全球市场:考察与预测 (到2028年)

Global Antibody Drug Conjugates Contract Manufacturing Market Insights, Forecast to 2028
出版日期: | 出版商: QYResearch | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球抗体药物复合体受託製造的市场规模，由于COVID-19大流行和俄罗斯、乌克兰战争的影响，预计2023年达到33亿131万美元，至2029年达到93亿3,376万美元的修改规模，在预测期间内 (2023年～2029年) 以18.91％的年复合成长率成长。

美国、加拿大的抗体药物复合体受託製造的市场规模，预计从2023年的11亿8,154万美元，2029年达到36亿9,897万美元，在预测期间内 (2024年～2029年) 以20.95％的年复合成长率成长。

中国的抗体药物复合体受託製造的市场规模，预计从2023年的4亿2,257万美元，2029年达到11亿3,592万美元，在预测期间内 (2024年～2029年) 以17.92％的年复合成长率成长。

欧洲的抗体药物复合体受託製造的市场规模，从2023年的9亿2,437万美元，2029年达到26亿2,559万美元，在预测期间内 (2024年～2029年) 以19％的年复合成长率被认为成长。

本报告提供全球抗体药物复合体受託製造的市场相关分析，各类型、各用途、各地区 (各国) 的市场趋势预测 (2018年～2029年)，主要企业的简介等相关调查。

目录

第1章 调查概要

  • 调查范围
  • 各种类的市场分析
    • 市场规模、成长率:各类型 (2018年、2022年、2029年)
    • IgG1
    • IgG4
  • 各用途的市场
    • 市场占有率:各用途 (2018年、2022年、2029年)
    • 固态肿瘤
    • 恶性血液肿瘤
  • 前提、规定条件
  • 分析对像
  • 分析期间

第2章 全球成长趋势

  • 全球抗体药物复合体受託製造市场展望 (2018年～2029年)
  • 抗体药物复合体受託製造的成长趋势:各地区
  • 抗体药物复合体受託製造的市场动态

第3章 各主要企业的竞争情形

  • 全球抗体药物复合体受託製造的收益:各企业
  • 市场占有率:企业的各类型 (第一级，第二级，第三级)
  • 分析对像企业:抗体药物复合体受託製造的各收益的排行榜 (2021年、2022年、2023年)
  • 全球抗体药物复合体受託製造市场集中度
  • 抗体药物复合体受託製造的主要企业:总公司、提供区域
  • 抗体药物复合体受託製造的主要企业:产品与其用途
  • 抗体药物复合体受託製造的主要企业:成立时期

第4章 抗体药物复合体受託製造:各种类的明细资料

  • 过去的市场规模:各类型 (2018年～2023年)
  • 市场规模的预测:各类型 (2024年～2029年)

第5章 抗体药物复合体受託製造:各用途的明细资料

  • 过去的市场规模:各用途 (2018年～2023年)
  • 市场规模的预测:各用途 (2024年～2029年)

第6章 北美

  • 北美的抗体药物复合体受託製造的市场规模 (2018年～2029年)
  • 北美的抗体药物复合体受託製造的市场规模:各类型
  • 北美的抗体药物复合体受託製造的市场规模:各用途
  • 北美的抗体药物复合体受託製造的市场规模:各国
    • 美国
    • 加拿大

第7章 欧洲

  • 欧洲的抗体药物复合体受託製造的市场规模 (2018年～2029年)
  • 欧洲的抗体药物复合体受託製造的市场规模:各类型
  • 欧洲的抗体药物复合体受託製造的市场规模:各用途
  • 欧洲的抗体药物复合体受託製造的市场规模:各国
    • 德国
    • 法国
    • 英国
    • 义大利
    • 俄罗斯
    • 北欧各国

第8章 中国

  • 中国的抗体药物复合体受託製造的市场规模 (2018年～2029年)
  • 中国的抗体药物复合体受託製造的市场规模:各类型
  • 中国的抗体药物复合体受託製造的市场规模:各用途

第9章 亚洲 (中国以外)

  • 亚洲的抗体药物复合体受託製造的市场规模 (2018年～2029年)
  • 亚洲的抗体药物复合体受託製造的市场规模:各类型
  • 亚洲的抗体药物复合体受託製造的市场规模:各用途
  • 亚洲的抗体药物复合体受託製造的市场规模:各地区
    • 日本
    • 韩国
    • 台湾
    • 东南亚
    • 印度
    • 澳洲

第10章 中东、非洲、南美

  • 中东、非洲、南美的抗体药物复合体受託製造的市场规模 (2018年～2029年)
  • 中东、非洲、南美的抗体药物复合体受託製造的市场规模:各类型
  • 中东、非洲、南美的抗体药物复合体受託製造的市场规模:各用途
  • 中东、非洲、南美的抗体药物复合体受託製造的市场规模:各国
    • 巴西
    • 墨西哥
    • 土耳其
    • 以色列
    • GCC各国

第11章 主要企业的简介

  • Lonza Group
  • Merck
  • Recipharm
  • Thermo Fisher Scientific
  • Abbvie
  • Piramal Pharma Solutions
  • Catalent
  • Sterling Pharma Solutions
  • Curia
  • Novasep
  • Ajinomoto Bio-Pharma Services
  • BSP Pharmaceuticals
  • Cerbios-Pharma
  • GBI (Goodwin Biotechnology)

第12章 分析师的见解/结论

第13章 附录

Market Analysis and Insights:

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antibody Drug Conjugates Contract Manufacturing estimated at US$ 3,301.31 million in the year 2023, is projected to reach a revised size of US$ 9,333.76 million by 2029, growing at a CAGR of 18.91% % during the forecast period 2023-2029.

The US & Canada market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 1,181.54 million in 2023 to reach $ 3,698.97 million by 2029, at a CAGR of 20.95 % during the forecast period of 2024 through 2029.

The China market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 422.57 million in 2023 to reach $ 1,135.92 million by 2029, at a CAGR of 17.92% during the forecast period of 2024 through 2029.

The Europe market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 924.37 million in 2023 to reach $ 2,625.59 million by 2029, at a CAGR of 19% during the forecast period of 2024 through 2029.

The global key companies of Antibody Drug Conjugates Contract Manufacturing include: Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, and Curia, etc. In 2022, the global top five players had a share approximately 68.46 % in terms of revenue.

Report Includes

This report presents an overview of global market for Antibody Drug Conjugates Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Antibody Drug Conjugates Contract Manufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antibody Drug Conjugates Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Drug Conjugates Contract Manufacturingrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Antibody Drug Conjugates Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Antibody Drug Conjugates Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, and Curia, etc.

By Company

  • Lonza Group
  • Merck KGaA
  • Recipharm
  • Thermo Fisher Scientific
  • Abbvie
  • Piramal Pharma Solutions
  • Catalent
  • Sterling Pharma Solutions
  • Curia
  • Novasep
  • Ajinomoto Bio-Pharma Services
  • BSP Pharmaceuticals
  • Cerbios-Pharma
  • Goodwin Biotechnology

Segment by Type

  • IgG1
  • IgG4

Segment by Application

  • Solid Tumors
  • Hematological Malignancies

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Antibody Drug Conjugates Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antibody Drug Conjugates Contract Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Drug Conjugates Contract Manufacturingrevenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 IgG1
    • 1.2.3 IgG4
  • 1.3 Market by Application
    • 1.3.1 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2018 VS 2022 VS 2029
    • 1.3.2 Solid Tumors
    • 1.3.3 Hematological Malignancies
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Perspective (2018-2029)
  • 2.2 Global Antibody Drug Conjugates Contract Manufacturing Growth Trends by Region
    • 2.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Region (2018-2023)
    • 2.2.3 Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2024-2029)
  • 2.3 Antibody Drug Conjugates Contract Manufacturing Market Dynamics
    • 2.3.1 Antibody Drug Conjugates Contract Manufacturing Industry Trends
    • 2.3.2 Antibody Drug Conjugates Contract Manufacturing Market Drivers
    • 2.3.3 Antibody Drug Conjugates Contract Manufacturing Market Challenges

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Antibody Drug Conjugates Contract Manufacturing by Players
    • 3.1.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2018-2023)
    • 3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2018-2023)
  • 3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio
    • 3.4.1 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugates Contract Manufacturing Revenue in 2022
  • 3.5 Global Key Players of Antibody Drug Conjugates Contract Manufacturing Head office and Area Served
  • 3.6 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
  • 3.7 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Established

4 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Type

  • 4.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Type (2018-2023)
  • 4.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2024-2029)

5 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Application

  • 5.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Application (2018-2023)
  • 5.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 6.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 6.2.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 6.2.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 6.2.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 6.3.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 6.3.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 6.4 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
    • 6.4.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023)
    • 6.4.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 7.2.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 7.2.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 7.2.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 7.3.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 7.3.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 7.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
    • 7.4.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023)
    • 7.4.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 8.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 8.2.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 8.2.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 8.2.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 8.3 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 8.3.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 8.3.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 9.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 9.2.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 9.2.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 9.2.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 9.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 9.3.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 9.3.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 9.3.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 9.4 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region
    • 9.4.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023)
    • 9.4.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Lonza Group
    • 11.1.1 Lonza Group Company Details
    • 11.1.2 Lonza Group Business Overview
    • 11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.1.4 Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.2 Merck
    • 11.2.1 Merck Company Details
    • 11.2.2 Merck Business Overview
    • 11.2.3 Merck Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.2.4 Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.3 Recipharm
    • 11.3.1 Recipharm Company Details
    • 11.3.2 Recipharm Business Overview
    • 11.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.3.4 Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.4 Thermo Fisher Scientific
    • 11.4.1 Thermo Fisher Scientific Company Details
    • 11.4.2 Thermo Fisher Scientific Business Overview
    • 11.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.4.4 Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.5 Abbvie
    • 11.5.1 Abbvie Company Details
    • 11.5.2 Abbvie Business Overview
    • 11.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.5.4 Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.6 Piramal Pharma Solutions
    • 11.6.1 Piramal Pharma Solutions Company Details
    • 11.6.2 Piramal Pharma Solutions Business Overview
    • 11.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.6.4 Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.7 Catalent
    • 11.7.1 Catalent Company Details
    • 11.7.2 Catalent Business Overview
    • 11.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.7.4 Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.8 Sterling Pharma Solutions
    • 11.8.1 Sterling Pharma Solutions Company Details
    • 11.8.2 Sterling Pharma Solutions Business Overview
    • 11.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.8.4 Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.9 Curia
    • 11.9.1 Curia Company Details
    • 11.9.2 Curia Business Overview
    • 11.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.9.4 Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.10 Novasep
    • 11.10.1 Novasep Company Details
    • 11.10.2 Novasep Business Overview
    • 11.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.10.4 Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.11 Ajinomoto Bio-Pharma Services
    • 11.11.1 Ajinomoto Bio-Pharma Services Company Details
    • 11.11.2 Ajinomoto Bio-Pharma Services Business Overview
    • 11.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.11.4 Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.12 BSP Pharmaceuticals
    • 11.12.1 BSP Pharmaceuticals Company Details
    • 11.12.2 BSP Pharmaceuticals Business Overview
    • 11.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.12.4 BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.13 Cerbios-Pharma
    • 11.13.1 Cerbios-Pharma Company Details
    • 11.13.2 Cerbios-Pharma Business Overview
    • 11.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.13.4 Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.14 GBI (Goodwin Biotechnology)
    • 11.14.1 GBI (Goodwin Biotechnology) Company Details
    • 11.14.2 GBI (Goodwin Biotechnology) Business Overview
    • 11.14.3 GBI (Goodwin Biotechnology) Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.14.4 GBI (Goodwin Biotechnology) Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

  • Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Key Players of IgG1
  • Table 3. Key Players of IgG4
  • Table 4. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)
  • Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2018-2023)
  • Table 8. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2024-2029)
  • Table 10. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2018-2023) & (US$ Million)
  • Table 11. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players (2018-2023)
  • Table 12. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2021)
  • Table 13. Global Antibody Drug Conjugates Contract Manufacturing Industry Ranking 2021 VS 2022 VS 2023
  • Table 14. Global 5 Largest Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue (CR5 and HHI) & (2018-2023)
  • Table 15. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Headquarters and Area Served
  • Table 16. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
  • Table 17. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Established
  • Table 18. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 19. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2018-2023)
  • Table 20. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 21. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2024-2029)
  • Table 22. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 23. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2018-2023)
  • Table 24. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 25. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2024-2029)
  • Table 26. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 27. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 28. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 30. North America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 31. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
  • Table 32. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)
  • Table 33. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 36. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 37. Europe Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 38. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
  • Table 39. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)
  • Table 40. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 41. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 42. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 43. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 44. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 45. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 46. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 47. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 48. Asia Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 49. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)
  • Table 50. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2024-2029) & (US$ Million)
  • Table 51. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 52. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 53. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 54. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 55. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 56. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)
  • Table 58. Lonza Group Company Details
  • Table 59. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product
  • Table 60. Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 61. Merck Company Details
  • Table 62. Merck Antibody Drug Conjugates Contract Manufacturing Product
  • Table 63. Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 64. Recipharm Company Details
  • Table 65. Recipharm Antibody Drug Conjugates Contract Manufacturing Product
  • Table 66. Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 67. Thermo Fisher Scientific Company Details
  • Table 68. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product
  • Table 69. Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 70. Abbvie Company Details
  • Table 71. Abbvie Antibody Drug Conjugates Contract Manufacturing Product
  • Table 72. Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 73. Piramal Pharma Solutions Company Details
  • Table 74. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product
  • Table 75. Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 76. Catalent Company Details
  • Table 77. Catalent Antibody Drug Conjugates Contract Manufacturing Product
  • Table 78. Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 79. Sterling Pharma Solutions Company Details
  • Table 80. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product
  • Table 81. Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 82. Curia Company Details
  • Table 83. Curia Antibody Drug Conjugates Contract Manufacturing Product
  • Table 84. Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 85. Novasep Company Details
  • Table 86. Novasep Antibody Drug Conjugates Contract Manufacturing Product
  • Table 87. Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 88. Ajinomoto Bio-Pharma Services Company Details
  • Table 89. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product
  • Table 90. Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 91. BSP Pharmaceuticals Company Details
  • Table 92. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product
  • Table 93. BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 94. Cerbios-Pharma Company Details
  • Table 95. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product
  • Table 96. Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 97. GBI (Goodwin Biotechnology) Company Details
  • Table 98. GBI (Goodwin Biotechnology) Antibody Drug Conjugates Contract Manufacturing Product
  • Table 99. GBI (Goodwin Biotechnology) Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 100. Research Programs/Design for This Report
  • Table 101. Key Data Information from Secondary Sources
  • Table 102. Key Data Information from Primary Sources
  • Table 103. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Type: 2022 VS 2029
  • Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 4. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2022 VS 2029
  • Figure 5. Antibody Drug Conjugates Contract Manufacturing Report Years Considered
  • Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 7. Global Antibody Drug Conjugates Contract Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 8. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region: 2022 VS 2029
  • Figure 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players in 2022
  • Figure 10. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2022)
  • Figure 11. The Top 10 and 5 Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue in 2022
  • Figure 12. North America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 13. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 14. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2029)
  • Figure 16. United States Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 17. Canada Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 18. Europe Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 20. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 21. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2029)
  • Figure 22. Germany Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. France Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. U.K. Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Italy Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Russia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. Nordic Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. China Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 30. China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 31. Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 33. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 34. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2018-2029)
  • Figure 35. Japan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. South Korea Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. China Taiwan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 38. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 39. India Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 40. Australia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 43. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 44. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2029)
  • Figure 45. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Israel Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. GCC Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Lonza Group Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 51. Merck Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 52. Recipharm Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 54. Abbvie Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 55. Piramal Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 56. Catalent Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 57. Sterling Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 58. Curia Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 59. Novasep Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 60. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 61. BSP Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 62. Cerbios-Pharma Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 63. GBI (Goodwin Biotechnology) Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed